Cargando…
Resectability of Pancreatic Cancer Is in the Eye of the Observer: A Multicenter, Blinded, Prospective Assessment of Interobserver Agreement on NCCN Resectability Status Criteria
OBJECTIVES: To determine the reproducibility of the National Comprehensive Cancer Network (NCCN) resectability status classification for pancreatic cancer. BACKGROUND: The NCCN classification defines 3 resectability classes (resectable, borderline resectable, locally advanced), according to vascular...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455302/ https://www.ncbi.nlm.nih.gov/pubmed/37635813 http://dx.doi.org/10.1097/AS9.0000000000000087 |
_version_ | 1785096419561963520 |
---|---|
author | Giannone, Fabio Capretti, Giovanni Abu Hilal, Mohammed Boggi, Ugo Campra, Donata Cappelli, Carla Casadei, Riccardo De Luca, Raffaele Falconi, Massimo Giannotti, Gabriele Gianotti, Luca Girelli, Roberto Gollini, Paola Ippolito, Davide Limerutti, Giorgio Maganuco, Lorenzo Malagnino, Valeria Malleo, Giuseppe Morone, Mario Mosconi, Cristina Mrakic, Federica Palumbo, Diego Salvia, Roberto Sgroi, Salvatore Zerbi, Alessandro Balzano, Gianpaolo |
author_facet | Giannone, Fabio Capretti, Giovanni Abu Hilal, Mohammed Boggi, Ugo Campra, Donata Cappelli, Carla Casadei, Riccardo De Luca, Raffaele Falconi, Massimo Giannotti, Gabriele Gianotti, Luca Girelli, Roberto Gollini, Paola Ippolito, Davide Limerutti, Giorgio Maganuco, Lorenzo Malagnino, Valeria Malleo, Giuseppe Morone, Mario Mosconi, Cristina Mrakic, Federica Palumbo, Diego Salvia, Roberto Sgroi, Salvatore Zerbi, Alessandro Balzano, Gianpaolo |
author_sort | Giannone, Fabio |
collection | PubMed |
description | OBJECTIVES: To determine the reproducibility of the National Comprehensive Cancer Network (NCCN) resectability status classification for pancreatic cancer. BACKGROUND: The NCCN classification defines 3 resectability classes (resectable, borderline resectable, locally advanced), according to vascular invasion. It is used to recommend different approaches and stratify patients during clinical trials. METHODS: Prospective, multicenter, observational study (trial ID: NCT03673423). Main outcome measure was the interobserver agreement of tumor assignment to different resectability classes and quantification of vascular invasion degrees. Agreement was measured by Fleiss’ k (k = 1 perfect agreement; k = 0 agreement by chance). Sixty-nine computed tomography (CT) scans of pathologically confirmed pancreatic adenocarcinoma were independently reviewed in a blinded fashion by 22 observers from 11 hospitals (11 surgeons and 11 radiologists). Rating differences between surgeons or radiologists and between hospitals with different volumes (≥60 or <60 resections/year) were assessed. RESULTS: Complete agreement among 22 observers was recorded in 5 CT scans (7.2%), whereas 25 CT scans (36.2%) were variously assigned to all 3 resectability classes. Interobserver agreement varied from fair to moderate (Fleiss’ k range: 0.282–0.555), with the lowest agreement for borderline resectable tumors. Assessing vascular contact ≤180° had the lowest agreement for all vessels (k range: 0.196–0.362). The highest concordance was recorded for venous invasion >180° (k range: 0.619–0.756). Neither reviewers’ specialty nor hospital volume influenced the agreement. CONCLUSIONS: There is high variability in the assignment to resectability categories, which may compromise the reliability of treatments recommendations and the evidence of trials stratifying patients in resectability classes. Criteria should be revised to allow a reproducible classification. |
format | Online Article Text |
id | pubmed-10455302 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wolters Kluwer Health, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104553022023-08-26 Resectability of Pancreatic Cancer Is in the Eye of the Observer: A Multicenter, Blinded, Prospective Assessment of Interobserver Agreement on NCCN Resectability Status Criteria Giannone, Fabio Capretti, Giovanni Abu Hilal, Mohammed Boggi, Ugo Campra, Donata Cappelli, Carla Casadei, Riccardo De Luca, Raffaele Falconi, Massimo Giannotti, Gabriele Gianotti, Luca Girelli, Roberto Gollini, Paola Ippolito, Davide Limerutti, Giorgio Maganuco, Lorenzo Malagnino, Valeria Malleo, Giuseppe Morone, Mario Mosconi, Cristina Mrakic, Federica Palumbo, Diego Salvia, Roberto Sgroi, Salvatore Zerbi, Alessandro Balzano, Gianpaolo Ann Surg Open Original Study OBJECTIVES: To determine the reproducibility of the National Comprehensive Cancer Network (NCCN) resectability status classification for pancreatic cancer. BACKGROUND: The NCCN classification defines 3 resectability classes (resectable, borderline resectable, locally advanced), according to vascular invasion. It is used to recommend different approaches and stratify patients during clinical trials. METHODS: Prospective, multicenter, observational study (trial ID: NCT03673423). Main outcome measure was the interobserver agreement of tumor assignment to different resectability classes and quantification of vascular invasion degrees. Agreement was measured by Fleiss’ k (k = 1 perfect agreement; k = 0 agreement by chance). Sixty-nine computed tomography (CT) scans of pathologically confirmed pancreatic adenocarcinoma were independently reviewed in a blinded fashion by 22 observers from 11 hospitals (11 surgeons and 11 radiologists). Rating differences between surgeons or radiologists and between hospitals with different volumes (≥60 or <60 resections/year) were assessed. RESULTS: Complete agreement among 22 observers was recorded in 5 CT scans (7.2%), whereas 25 CT scans (36.2%) were variously assigned to all 3 resectability classes. Interobserver agreement varied from fair to moderate (Fleiss’ k range: 0.282–0.555), with the lowest agreement for borderline resectable tumors. Assessing vascular contact ≤180° had the lowest agreement for all vessels (k range: 0.196–0.362). The highest concordance was recorded for venous invasion >180° (k range: 0.619–0.756). Neither reviewers’ specialty nor hospital volume influenced the agreement. CONCLUSIONS: There is high variability in the assignment to resectability categories, which may compromise the reliability of treatments recommendations and the evidence of trials stratifying patients in resectability classes. Criteria should be revised to allow a reproducible classification. Wolters Kluwer Health, Inc. 2021-08-11 /pmc/articles/PMC10455302/ /pubmed/37635813 http://dx.doi.org/10.1097/AS9.0000000000000087 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Original Study Giannone, Fabio Capretti, Giovanni Abu Hilal, Mohammed Boggi, Ugo Campra, Donata Cappelli, Carla Casadei, Riccardo De Luca, Raffaele Falconi, Massimo Giannotti, Gabriele Gianotti, Luca Girelli, Roberto Gollini, Paola Ippolito, Davide Limerutti, Giorgio Maganuco, Lorenzo Malagnino, Valeria Malleo, Giuseppe Morone, Mario Mosconi, Cristina Mrakic, Federica Palumbo, Diego Salvia, Roberto Sgroi, Salvatore Zerbi, Alessandro Balzano, Gianpaolo Resectability of Pancreatic Cancer Is in the Eye of the Observer: A Multicenter, Blinded, Prospective Assessment of Interobserver Agreement on NCCN Resectability Status Criteria |
title | Resectability of Pancreatic Cancer Is in the Eye of the Observer: A Multicenter, Blinded, Prospective Assessment of Interobserver Agreement on NCCN Resectability Status Criteria |
title_full | Resectability of Pancreatic Cancer Is in the Eye of the Observer: A Multicenter, Blinded, Prospective Assessment of Interobserver Agreement on NCCN Resectability Status Criteria |
title_fullStr | Resectability of Pancreatic Cancer Is in the Eye of the Observer: A Multicenter, Blinded, Prospective Assessment of Interobserver Agreement on NCCN Resectability Status Criteria |
title_full_unstemmed | Resectability of Pancreatic Cancer Is in the Eye of the Observer: A Multicenter, Blinded, Prospective Assessment of Interobserver Agreement on NCCN Resectability Status Criteria |
title_short | Resectability of Pancreatic Cancer Is in the Eye of the Observer: A Multicenter, Blinded, Prospective Assessment of Interobserver Agreement on NCCN Resectability Status Criteria |
title_sort | resectability of pancreatic cancer is in the eye of the observer: a multicenter, blinded, prospective assessment of interobserver agreement on nccn resectability status criteria |
topic | Original Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455302/ https://www.ncbi.nlm.nih.gov/pubmed/37635813 http://dx.doi.org/10.1097/AS9.0000000000000087 |
work_keys_str_mv | AT giannonefabio resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria AT caprettigiovanni resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria AT abuhilalmohammed resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria AT boggiugo resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria AT campradonata resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria AT cappellicarla resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria AT casadeiriccardo resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria AT delucaraffaele resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria AT falconimassimo resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria AT giannottigabriele resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria AT gianottiluca resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria AT girelliroberto resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria AT gollinipaola resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria AT ippolitodavide resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria AT limeruttigiorgio resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria AT maganucolorenzo resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria AT malagninovaleria resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria AT malleogiuseppe resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria AT moronemario resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria AT mosconicristina resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria AT mrakicfederica resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria AT palumbodiego resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria AT salviaroberto resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria AT sgroisalvatore resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria AT zerbialessandro resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria AT balzanogianpaolo resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria |